Pegbelfermin

DB15365Investigational

Pegbelfermin is under investigation in clinical trial NCT03486899 (A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis).

Mechanism: Pharmacologically active on Fibroblast growth factor receptor 1 and Beta-klotho
Curator reviewed
Also known as: BMS-986036

Resolves to

Compound

UNIIP5T1E46W5DCAS2089039-22-3

Targets

P11362FGFR1Q86Z14KLB

What you can answer from here — as of July 16, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

11Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Pegbelfermin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account